{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T03:12:57Z","timestamp":1781579577948,"version":"3.54.5"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"45","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1097\/md.0000000000008505","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T18:51:45Z","timestamp":1510167105000},"page":"e8505","source":"Crossref","is-referenced-by-count":7,"title":["Multiple adverse drug reactions and genetic polymorphism testing"],"prefix":"10.1097","volume":"96","author":[{"given":"Ana Luc\u00eda","family":"Arellano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Martin-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Monerris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"LLerena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mag\u00ed","family":"Farr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Montan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-42-20210309","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1081-1206(10)60637-0","article-title":"Multiple-drug intolerance syndrome: clinical findings and usefulness of challenge tests","volume":"99","author":"Schiavino","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R2-42-20210309","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/jch.12637","article-title":"Management of hypertensive patients with multiple drug intolerances: a single-center experience of a novel treatment algorithm","volume":"18","author":"Antoniou","year":"2016","journal-title":"J Clin Hypertens (Greenwich"},{"key":"R3-42-20210309","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.anai.2011.11.006","article-title":"Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management","volume":"108","author":"Macy","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"R4-42-20210309","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s40264-014-0236-x","article-title":"Multiple drug intolerance syndrome: a large-scale retrospective study","volume":"37","author":"Omer","year":"2014","journal-title":"Drug Saf"},{"key":"R5-42-20210309","first-page":"138","article-title":"Multiple drug intolerance: allergological and psychological findings","volume":"1","author":"Patriarca","year":"1991","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R6-42-20210309","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"R8-42-20210309","doi-asserted-by":"crossref","first-page":"S571","DOI":"10.2144\/000112044","article-title":"Development of a PCR-based strategy for CYP2D6 genotyping including gene multiplication of worldwide potential use","volume":"39","author":"Dorado","year":"2005","journal-title":"Biotechniques"},{"key":"R9-42-20210309","first-page":"391","article-title":"The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects","volume":"76","author":"Lynch","year":"2007","journal-title":"Am Fam Physician"},{"key":"R10-42-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfq374","article-title":"Genetic polymorphism and toxicology\u2014with emphasis on cytochrome p450","volume":"120","author":"Johansson","year":"2011","journal-title":"Toxicol Sci"},{"key":"R11-42-20210309","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1124\/pr.58.3.6","article-title":"Pharmacogenetics, drug metabolizing enzymes, and clinical practice","volume":"58","author":"Gardiner","year":"2006","journal-title":"Pharmacol Rev"},{"key":"R12-42-20210309","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/tpj.2016.47","article-title":"High frequency of CYP2D6 ultrarapid metabolizers in Spain: controversy about their misclassification in worldwide population studies","volume":"16","author":"Naranjo","year":"2016","journal-title":"Pharmacogenomics J"},{"key":"R13-42-20210309","first-page":"e1289","article-title":"Proposal for a pharmacogenetic decision algorithm","volume":"9","author":"Alzghari","year":"2017","journal-title":"Cureus"},{"key":"R14-42-20210309","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.2013.2","article-title":"Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants","volume":"93","author":"Hicks","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"R15-42-20210309","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.tips.2004.02.007","article-title":"Pharmacogenetics of cytrochrome P450 and its applications in drug therapy: the past, present and future","volume":"25","author":"Ingelman-Sundberg","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"R16-42-20210309","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1373\/clinchem.2004.041327","article-title":"Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy","volume":"51","author":"Steimer","year":"2005","journal-title":"Clin Chem"},{"key":"R17-42-20210309","first-page":"71","article-title":"Tricyclic antidepressants: a review of their toxicology","volume":"4","author":"Fiori","year":"1977","journal-title":"Curr Dev Psychopharmacol"},{"key":"R18-42-20210309","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/bmj.321.7276.1608","article-title":"Hear my song: auditory hallucinations with tramadol hydrochloride","volume":"321","author":"Keeley","year":"2000","journal-title":"BMJ"},{"key":"R19-42-20210309","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/17843286.1996.11718509","article-title":"Nightmares and hallucinations after long-term intake of tramadol combined with antidepressants","volume":"51","author":"Devulder","year":"1996","journal-title":"Acta Clin Belg"},{"key":"R20-42-20210309","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/sj.tpj.6500285","article-title":"Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity","volume":"5","author":"Ingelman-Sundberg","year":"2005","journal-title":"Pharmacogenomics J"},{"key":"R21-42-20210309","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-200730050-00007","article-title":"An evaluation of the cardiovascular safety profile of duloxetine: findings from 42 placebo-controlled studies","volume":"30","author":"Wernicke","year":"2007","journal-title":"Drug Saf"},{"key":"R22-42-20210309","first-page":"197","article-title":"Somatic complications of psychotropic medications in a patient with multiple CYP2 drug metabolism deficiencies","volume":"71","author":"Rua\u00f1o","year":"2007","journal-title":"Conn Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000008505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:39:27Z","timestamp":1620959967000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201711100-00042"}},"subtitle":["A case report with negative result"],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":21,"journal-issue":{"issue":"45","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000008505","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]}}}